Cite
HARVARD Citation
Xiao, Y. et al. (n.d.). A157 REAL-WORLD TIGHT OBJECTIVE MONITORING WITH ADALIMUMAB LEADS TO EARLIER DOSE OPTIMIZATION AND HIGHER CLINICAL REMISSION RATES AT 12 MONTHS.. Journal of the Canadian Association of Gastroenterology. pp. 163-164. [Online].